Literature DB >> 11454417

The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior.

P Feng1, Y Ma, G W Vogel.   

Abstract

The immature brain is much more sensitive to abnormal experience, particularly sleep deprivation, drug exposure, and maternal separation. The critical time period during which features in the brain's susceptibility to such experience change, however, has not yet been determined. In previous studies on rats, we found that neonatal treatment with clomipramine (CLI) during postnatal days 8--21 (P8-21) produced behavioral and physiological abnormalities in adult rats that resembled the abnormalities found in human endogenous depression. The objective of the present study is to determine (1) the critical (more specifically, the latest) time frame in which CLI treatment will produce adult depression and (2) the shortest treatment window during which CLI can induce adult depression. Male rats were neonatally treated with CLI (20 mg/kg, sc) twice daily or with an equivolume of saline. The treatment windows were P12--17, P14--20, P16--22, and P12--15. Six variables, including number of mounts, intromission, ejaculation, mount latency, ejaculation latency, and post-ejaculation interval, were measured visually between the ages of 4 and 5 months. Rats treated with CLI showed significant sexual impairment in treatment windows P12--17 and P14--20 and slight sexual deficiency in the short window P12--15. No significant sexual impairment was found in window P16--22. We concluded that P14--20 was the latest window during which CLI treatment produces adult sexual deficiency and that 6 days might be the shortest treatment window to produce significant behavior abnormalities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454417     DOI: 10.1016/s0165-3806(01)00158-4

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  10 in total

1.  Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat.

Authors:  Sharonda S Harris; Dorota Maciag; Kimberly L Simpson; Rick C S Lin; Ian A Paul
Journal:  Brain Res       Date:  2011-10-20       Impact factor: 3.252

2.  Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice.

Authors:  Maxine Norcross; Poonam Mathur; Mathur Poonam; Abigail J Enoch; Rose-Marie Karlsson; Jonathan L Brigman; Heather A Cameron; Judith Harvey-White; Andrew Holmes
Journal:  Psychopharmacology (Berl)       Date:  2008-07-02       Impact factor: 4.530

3.  Assessment of the septal area neuronal activity during penile erections in rapid eye movement sleep and waking in the rats.

Authors:  Kamalesh K Gulia; Yukihiko Kayama; Yoshimasa Koyama
Journal:  J Physiol Sci       Date:  2017-08-02       Impact factor: 2.781

Review 4.  Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?

Authors:  Susan L Andersen; Carryl P Navalta
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

5.  Neurobehavioral manifestations of developmental impairment of the brain.

Authors:  Michal Dubovický
Journal:  Interdiscip Toxicol       Date:  2010-06

6.  Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment.

Authors:  Dorota Maciag; Lashondra Williams; David Coppinger; Ian A Paul
Journal:  Eur J Pharmacol       Date:  2006-02-14       Impact factor: 4.432

Review 7.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

8.  Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine.

Authors:  P Feng; D Vurbic; Z Wu; Y Hu; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-09       Impact factor: 4.153

9.  The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse development.

Authors:  Antonio Di Lieto; Tomi Rantamäki; Liisa Vesa; Sudhirkumar Yanpallewar; Hanna Antila; Jesse Lindholm; Maribel Rios; Lino Tessarollo; Eero Castrén
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

10.  Early-life sleep disruption increases parvalbumin in primary somatosensory cortex and impairs social bonding in prairie voles.

Authors:  Carolyn E Jones; Ryan A Opel; Mara E Kaiser; Alex Q Chau; Jazmine R Quintana; Michelle A Nipper; Deborah A Finn; Elizabeth A D Hammock; Miranda M Lim
Journal:  Sci Adv       Date:  2019-01-30       Impact factor: 14.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.